Lung Cancer: Scalpels, Beams, Drugs, and Probes

J. D. Minna, D. C. Ihde, E. J. Glatstein

Research output: Contribution to journalEditorialpeer-review

9 Scopus citations

Abstract

Ninety percent of the 149,000 people who will have lung cancer in the United States this year will die of their disease,1 and the physicians caring for them must decide the best way to confront a bleak situation. The article by the Lung Cancer Study Group in this issue of the Journal2 shows the limitations of two components (surgery and radiotherapy) of our triad of weapons in the treatment of lung cancer. In this prospective randomized clinical trial, postoperative adjuvant chest irradiation was given to patients with resected epidermoid (squamous-cell) carcinoma and positive hilar (N1) or mediastinal (N2) nodes in.

Original languageEnglish (US)
Pages (from-to)1411-1414
Number of pages4
JournalNew England Journal of Medicine
Volume315
Issue number22
DOIs
StatePublished - Nov 27 1986

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Lung Cancer: Scalpels, Beams, Drugs, and Probes'. Together they form a unique fingerprint.

Cite this